Optel Logo

Optel, Inc


The University of Rochester is partnering with Optel, Inc., to develop and build commercial clinical prototypes to characterize and assist in the management of dry eye disease (DED). These prototypes are based on a proprietary laboratory instrument developed at the University of Rochester, The Institute of Optics and Flaum Eye Institute that has been shown to characterize dye eye and the effect of several types of eye drops. DED affects an estimated 40 million individuals in the U.S. and given its predisposition and increased prevalence with age, along with its association with cataract and refractive surgery, incidence is predicted to increase with the aging population and increased use of digital displays that alters blink behavior.


Jay Eastman
Chief Executive

View More Awardee Profiles

Exhibitor Inquiry

Attendee Request Form: 2023 Hardware Prototyping Workshop
Thanks for your interest in this resource, fill out the information below to download.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.